Abstract Angiotensin-converting enzyme 2 (ACE2), a counter regulator of the renin-
angiotensin system, provides protection against several chronic diseases. Besides chronic …

Alteration in gut microbiota has been associated with COVID-19. However, the underlying
mechanisms remain poorly understood. Here, we outlined three potential interconnected …

Abstract The coronavirus disease 2019 (COVID-19) pandemic is an ongoing global health
crisis causing major challenges for clinical care in patients with gastrointestinal diseases …

Mesenchymal stem cell (MSC) therapy is a promising candidate for inflammatory bowel
disease (IBD) treatment, while overcoming the limitations of naive seeding cells function and …

Since its first outbreak in 2020, the pandemic caused by the Severe Acute Respiratory
Syndrome-Coronavirus-2 (SARS-CoV-2) has caused the death of almost 7 million people …

Abstract Background and Aims Age is a major prognostic factor for COVID-19 outcomes. The
effect of inflammatory bowel disease [IBD] activity on COVID-19 is unclear. We examined the …

Bile acids are steroids generated at the interface of host and intestinal microbiota. While
primary bile acids are generated in the liver from cholesterol metabolism, secondary bile …

Gastrointestinal effects associated with Coronavirus Disease 2019 (COVID-19) are highly
variable for reasons that are not understood. In this study, we used intestinal organoid …

For a yet unknown reason, a substantial share of patients suffering from COVID-19 develop
long-lasting neuropsychiatric symptoms ranging from cognitive deficits to mood disorders …

Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) is the pathogenic agent
of Coronavirus-Induced Disease-2019 (COVID-19), a multi-organ syndrome which primarily …